Pfizer Inc.

As a caregiver, Liz shares her advice for anyone else supporting a loved one with prostate cancer: let them vent, listen, and be patient. This #NationalFamilyCaregiversMonth, explore more advice from caregivers like Liz at knowyourprostateplan.com/res…

Treatment resistance is one of the biggest challenges in advanced prostate cancer, making the disease more difficult to treat and highlighting the need for new approaches. At Pfizer, our researchers are studying EZH2 and whether targeting it could help restore sensitivity to hormone therapy. Learn more: bit.ly/3UwUcDl

BMI has been widely used to define obesity—but was it ever built for that job? The first episode of #ScienceWillWin’s latest season, with host @DrJoeHanson, explores BMI’s history, its limitations, and how science is moving toward a more nuanced understanding of #obesity. 🎧 Tune in here: on.pfizer.com/4jUNphk

250 years of American innovation have shown what’s possible when different minds and ideas come together. As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine. Learn more: bit.ly/4zh91sV #America250

See how Pfizer is using AI to help support precise and efficient manufacturing through our #GoldenBatch platform by turning complex production data into actionable insights. #ArtificialIntelligence #Manufacturing

Obesity isn’t simply about weight. It’s linked to inflammation, insulin resistance, and 200+ other conditions. Pfizer’s Lisa Tarasenko explains why treating obesity as a chronic disease, not a personal failing, is reshaping care. on.pfizer.com/3ULDmRq #ObesityCare #ChronicDisease

Pfizer Chief Oncology Officer Jeff Legos joined @TIME CEO Jessica Sibley ahead of #ESMO26 to discuss the future of cancer care and the urgency behind oncology innovation. Watch the conversation: time.com/branded-content/pfi…

Why do we weigh what we weigh? ⚖️ Season 7 of #ScienceWillWin explores the science behind #obesity—from hunger and hormones to genetics and real patient stories. Hosted by @DrJoeHanson of PBS's Be Smart. Coming soon. 🎧 Listen to the trailer today: on.pfizer.com/4i60XoZ

This #BreastCancerAwarenessMonth, explore Moments Beyond Cancer — a new initiative highlighting small, everyday actions to help people with #MetastaticBreastCancer maintain a sense of self beyond their diagnosis: thisislivingwithcancer.com/m…

Obesity isn’t a failure of willpower—it’s a chronic, multifactorial disease. Once weight is gained, the body works hard to keep it. Pfizer’s Dr. Manige Konig on what the science now tells us: on.pfizer.com/47jcKKh #Obesity #WeightStigma

When Josh Raub was diagnosed with Hodgkin lymphoma at age 29, he wondered if he would ever have a family. Today, the father of two has been in complete remission for 12 years. He reflects on what matters most: on.pfizer.com/47E5uIU

Finding participants is one of the biggest challenges in clinical research. #AI has the potential to help researchers identify potentially eligible volunteers faster, improve trial planning, and reduce administrative burden while keeping researchers and patients at the center of every decision. Learn more: on.pfizer.com/3VgbJji

Meet the people behind the science. This #WorldCancerResearchDay, our colleagues share what inspires them to advance cancer research and pursue breakthroughs that change patients’ lives.

Empowerment starts with education. From understanding routine #ProstateCancer screenings to next steps after a diagnosis, knowledge can help clarify the path ahead. This #ProstateCancerAwarenessMonth, learn how to take an active role in care at KnowYourProstatePlan.com.

When prostate cancer becomes resistant to traditional hormone therapies, new treatment approaches are needed. Pfizer researchers are studying EZH2 and exploring ways to potentially reprogram treatment resistance in metastatic prostate cancer. Learn more: on.pfizer.com/4hbgke2

💊 Most people never question whether the medicine in their cabinet is real, but the illicit worldwide counterfeit drugs network is vast, adaptive, and relentless. Here's how we’re helping combat counterfeits, disrupt criminal networks, and protect patients: on.pfizer.com/46k0854

What is one challenge in ATTR-CM you would like to highlight? At #ESCCongress in Munich, leading clinicians in the field told us what they thought. At Pfizer, we are committed to advancing understanding and awareness of ATTR-CM to improve outcomes for patients.

As #ESCCongress 2026 returns to Munich, early diagnosis and treatment initiation remain the biggest opportunity to improve outcomes in ATTR-CM, an underdiagnosed cause of heart failure. Explore how the landscape has evolved and what needs to happen next: bit.ly/3UIiVV0

250 years of American innovation have shown what’s possible when different minds and ideas come together. As we look to what’s next, Pfizer is proud to build on that spirit of innovation, continuing to advance science and explore what’s possible for the future of medicine. #America250